| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.51 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0008 |